LYDIA YACOUB

• Senior Account Specialist managing life cycle transition phase with increasing responsibility for all UAE.
• Achieved triple and double-digit growth in key accounts: NMC, MOH respectively, through focus on scientific discussions.
• Achieved best performer award 2022
• Worked strategically to manage LOE of Bridion in 2024-2025 through CFT collaboration with commercial, marketing & medical to handle different external key stakeholders, which lead to 4.5 M$ sales in 2025.
• Protecting brand presence through maintaining trusted scientific relationship & engagement with key stakeholders.
• Partnered with KSLs at main institutions to protocolize international guidelines as strategic action to support life cycle
• Planning strong tailored customer engagement to enhance therapeutic choice of treatment across all accounts while handling concerns, DRG & cost pressure gaining support from VD&A.
• GIG in 2023: content tagging specialist, which enhanced cross-functional collaboration with marketing teams across GCC and creative third party agencies to train them on how to properly tag promotional & non-promotional assets on Veeva Vault, to feed data into an innovative Al application, which will lead to wealth of benefits as campaign analytics, better efficiency & personalization of content according to customer persona plus better content search and management

• Established Diabetes Franchise in DHA with continuous growth record, differentiation versus competition & successful Steglatro launch
• Successful inclusion of Janumet XR in DHA, first case of total replacement in region.
• Conducting series of scientific mini symposiums as launch events to enhance clinical understanding of therapies
• Established MSD diabetes club, developing new speakers & engaging KSLs, in both local & international events
• Achieved best customer engagement award in Gulf at Diabetes Masterclass on successive years 2019, 2020 & 2022, with excellence in supporting HCPs understanding of appropriate therapy choice based on guidelines, clinical & safety information
• On job marketing assignment (2020-2022) Core member of digital enablement scrum team to create omnichannel marketing campaign that was strategic in diabetes life cycle management, role included project management of content creation of promotional & non-promotional material linked to guidelines recommendations such as: CLM, rep-enabled emails, interactive MDE (email campaign) to personalize appropriate choice of treatment for each patient, understanding HCPs perspective & current practice, while providing valuable medical information at-a-glance.
• This assignment included project management skills and CFT collaboration with marketing, medical, creative agencies and training entire diabetes team on proper implementation of campaign according to different personalized content for different patient profiles and track campaign implementation & analytics

• Lead initiative for Januvia inclusion in Kuwait's Primary Health Care, July 2011 through communication of clinical value with HCPs
• Achieve and maintain highest market share for Januvia globally 53% in private market since June 2011
• Built excellent & strong relationship with diabetes & endocrinology KSLs, understanding healthcare system dynamics & stakeholders decision process
• Excellent team communication & support while being reference to new members with medical information, clinical studies interpretation & handling HCPs medical information questions
• Successfully pass KAM & FLM assessments in Jan & Apr 2013 respectively
• Successful completion of Future Leads program: 2011-2012 program included 3 on job assignments:

1- KAM Military of Defense-Kuwait

2- Mentoring newly hired diabetes PSR

3- Creating & updating diabetes franchise consumption tracker for both PHCs & Private

• As part of Military of Defense Key Account Manager assignment:

a- Successful follow up 3 years tender 2013-2015

b- Work closely with external & internal key stakeholders to ensure inclusion & access of all of MSD products in contract, follow up on forecasting, prices, quantities & delivery

c- Successful negotiation with pharmacy to increase Januvia order by 70% based on previous consumption and to keep Januvia as only exclusive DPP4i in MOD tender, blocking competition for 3 years

• Successful achievement & significant growth record in different lines: Arcoxia, Fosamax, Zocor, Cozaar, Januvia & Janumet
• Successful Janumet launch in 2009
• Inclusion of Januvia in Military Of Defense & maintain exclusivity as only DPP4 inhibitor for 5 years
• Inclusion of Januvia in MOH in Dec 2010
• Successful exponential growth of Zocor in Primary healthcare clinics, being only statin for expats in Ministry Of Health

• Successful launches
• Building strong relationships with Scientific Leaders & key stakeholders and decision makers in chain pharmacies
• Build knowledge of main private hospitals & clinics all over Kuwait

• Successfully build basic understanding & knowledge of Kuwait private market, chain pharmacies & Key scientific stakeholders

• Best achiever of Ophthalmology unit in 2004
• Conduct successful launches & inclusions for glaucoma & ARMD
• Built excellent relationships with KSLs of Ophthalmology in Alexandria